Botham P A, Basketter D A, Maurer T, Mueller D, Potokar M, Bontinck W J
ICI plc, ECETOC, European Chemical Industry Ecology & Toxicology Centre, Brussels, Belgium.
Food Chem Toxicol. 1991 Apr;29(4):275-86. doi: 10.1016/0278-6915(91)90025-3.
With the exception of the Draize Test, the guinea-pig test methods currently accepted by regulatory authorities worldwide are well able to predict the potential of a material to cause skin sensitization. Nevertheless, (a) some methods are more sensitive than others (e.g. adjuvant tests are generally more sensitive than non-adjuvant tests); (b) methods cannot be sufficiently standardized to give full reproducibility of results between laboratories; and (c) most methods are based on subjective visual grading of skin reactions--difficulties thus arise when testing coloured or irritant materials. Laboratories must be able to show the sensitivity of the method(s) they use by demonstrating that positive reactions occur with mild/moderate contact allergens rather than the strong/extreme sensitizers currently recommended in certain guidelines, specifically in the EEC Test Method. The sensitivity of the adjuvant tests is such that it is possible to halve the minimum number of animals required by present regulatory guidelines without compromising the capacity of the tests to detect weak/mild sensitizers. A similar review has not yet been made for non-adjuvant tests. Alternative test methods, including some recently developed mouse models, offer several advantages, including more objective endpoints. These tests have not been extensively validated and this precludes their use at present for regulatory purposes other than to confirm the sensitization potential of a material. Two new test methods using mice, the Mouse Ear-swelling Test and the Local Lymph Node Assay, appear promising. They should undergo rigorous interlaboratory testing to determine their sensitivity and specificity. In vitro methods do not represent a viable alternative in the foreseeable future. An approach using quantitative structure-activity relationships is the most likely route to a non-animal model, but this will require considerable research, development and validation. Human sensitization tests have generally not been used for the classification of substances as non-sensitizers. This is because of an absence of internationally agreed test protocols, the lack of positive controls and because the methods for establishing the sensitivity of human tests are less developed than for animal tests. Nevertheless, for products for which direct human contact is intended, predictive tests in human volunteers can be considered. The EEC Directive for the Classification, Packaging and Labelling of Dangerous Substances provides a reasonable approach to the evaluation of skin sensitizers.(ABSTRACT TRUNCATED AT 400 WORDS)
除了德莱兹试验外,目前全球监管机构认可的豚鼠试验方法完全能够预测一种物质引起皮肤致敏的可能性。然而,(a)一些方法比其他方法更敏感(例如,佐剂试验通常比非佐剂试验更敏感);(b)方法无法充分标准化以在各实验室之间实现结果的完全重现性;并且(c)大多数方法基于对皮肤反应的主观视觉分级——因此在测试有色或刺激性物质时会出现困难。实验室必须能够通过证明在使用轻度/中度接触性变应原时出现阳性反应,而非目前某些指南(特别是在欧洲经济共同体试验方法中)推荐的强/极端致敏剂,来展示其所用方法的敏感性。佐剂试验的敏感性使得在不影响检测弱/轻度致敏剂能力的情况下,有可能将目前监管指南要求的动物最小数量减半。对于非佐剂试验尚未进行类似的审查。替代试验方法,包括一些最近开发的小鼠模型,具有若干优点,包括更客观的终点。这些试验尚未得到广泛验证,这使得它们目前除了用于确认一种物质的致敏潜力外,无法用于监管目的。两种使用小鼠的新试验方法,即小鼠耳肿胀试验和局部淋巴结测定法,看起来很有前景。它们应接受严格的实验室间测试以确定其敏感性和特异性。在可预见的未来,体外方法并非可行的替代方法。使用定量构效关系的方法是最有可能通向非动物模型的途径,但这需要大量的研究、开发和验证。人体致敏试验一般未用于将物质分类为非致敏剂。这是因为缺乏国际认可的试验方案、缺乏阳性对照,并且因为确定人体试验敏感性的方法不如动物试验方法发达。然而,对于打算直接与人体接触的产品,可以考虑在人体志愿者中进行预测性试验。欧洲经济共同体关于危险物质分类、包装和标签的指令为评估皮肤致敏剂提供了一种合理的方法。(摘要截选至400词)